title: Salivary gland dysfunction  (dry mouth) in patients  with advanced cancer.
abstract: Salivary gland dysfunction (SGD) is a common problem in patients with advanced cancer, and is associated with significant morbidity in this group of patients. The management of SGD involves treatment of the cause, treatment of the symptoms (preferably with saliva stimulants), prevention of the complications, and treatment of the complications. This article reviews the evidence for the clinical utility of various management strategies, highlighting those strategies that have been investigated in patients with advanced cancer.
authors: Royal Surgery County Hospital, Guildford, Durgery, England. adavies12@nhs.net
authors: Andrew
authors: A
authors: Davies
authors: Sally
authors: S
authors: Hall
mesh_terms: D000144:Acids, Acyclic / Q000627:therapeutic use; D002638:Chewing Gum; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D010166:Palliative Care; D010277:Parasympathomimetics / Q000627:therapeutic use; D012464:Saliva, Artificial / Q000627:therapeutic use; D014987:Xerostomia / Q000209:etiology / Q000628:therapy*
chemical_list: D000144:Acids, Acyclic; D002638:Chewing Gum; D010277:Parasympathomimetics; D012464:Saliva, Artificial